Open AccessTAK-536, a New AT1 Receptor Blocker, Improves Glucose Intolerance and Adipocyte Differentiation
Author(s) -
M IWAI,
Rui Chen,
Yuki Imura,
M HORIUCHI
Publication year - 2007
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2006.12.010
Subject(s) - medicine , adipocyte , angiotensin ii receptor type 1 , endocrinology , receptor , angiotensin ii , adipose tissue
The effects of a new AT(1) receptor blocker (ARB), TAK-536, on insulin resistance were explored using type 2 diabetic KK-A(y) mice and compared with those of candesartan cilexetil (candesartan).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom